Navigating Optionality
Building optionality is essential for success, but too much can lead to paralysis in decision-making. A pivotal partnership with AstraZeneca provided a significant cash boost for the company, allowing for growth and attracting top talent. Despite initial setbacks in stock performance after a historic IPO, the team remained committed to their vision, showcasing the resilience needed in the ever-evolving biotech landscape.In this clip
From this podcast
Masters of Scale
Extraordinary leaps need solid foundations, part 1, w/Moderna CEO Stéphane Bancel
Related Questions